Abstract:Wuhan is not only the first city to experience COVID-19 but is also among the first to emerge from the pandemic and currently has only 5 confirmed cases. The existence of asymptomatic carriers poses a threat for disease resurgence and also for virus transmission through transplantation. There are 2 types of asymptomatic carrier: the first is a recessive infection, with persistent but asymptomatic viral detection over 14 days or more, but with a relatively low-infectivity risk in the general community and unknown infection transmission risk from organ donation. The second group of asymptomatic cases are in the early stages of the incubation of the disease and become symptomatic over time but are contagious in the asymptomatic phase. To identify all asymptomatic carriers, Wuhan has carried out SARS-CoV-2 nucleic acid tests (NAT) for all city dwellers since May 14. As of May 24, 6 574 093 NAT tests have been completed, with a total of 227 new asymptomatic carriers and 1 new confirmed case.1 The asymptomatic infection rate in Wuhan has dropped from 0.5 per 1000 people2 to 0.03 per 1000 people. The outbreak of COVID-19 greatly slowed and then stopped organ donation and transplantation in Wuhan, but the decrease in the number of infections has allowed hospitals in Wuhan to carefully resume deceased donor organ donation and transplantation. Hyo-Lim Hong et al3 and Stephen Lagana et al4 have reported 2 cases of donor-derived transmission of COVID-19; therefore, a strategy is needed to prevent donor-derived transmission from all potential asymptomatic carriers. Because of the superficial understanding of COVID-19 and presence of asymptomatic infection in Wuhan, we instituted a protocol to prevent organ donor transmission of COVID-19. Before transplantation, both deceased donors and potential recipients undergo SARS-CoV-2 NAT and antibody tests as well as CT scans, which are repeated twice, to avoid the known false negative rates of single tests in COVID-19 patients and detect patients in the early stages of developing symptomatic disease. Donors and recipients must test negative twice to be eligible for transplant. To minimize transmission caused by asymptomatic carriers, potential deceased donors are quarantined in intensive care for >7 days while being tested. Suspected or confirmed COVID-19 patients would be eliminated from the donation process. From April 8, when Wuhan was reopened, to May 25, 43 cases of organ donation after brain death and 125 cases of organ transplant have been completed in Wuhan hospitals. There have been no cases of COVID-19 detected among organ transplant donors and recipients. This protocol may serve as a complex but necessary learning model for others.

Strategies to Halt 2019 Novel Coronavirus (Sars-Cov-2) Spread for Organ Transplantation Programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China

STRATEGIES TO HALT 2019 NOVEL CORONAVIRUS (COVID-19) SPREAD FOR ORGAN TRANSPLANTATION PROGRAMS AT THE SICHUAN ACADEMY OF MEDICAL SCIENCE AND SICHUAN PROVINCIAL PEOPLE’S HOSPITAL, CHINA

Lung transplantation during the outbreak of Coronavirus Disease 2019 in China

LUNG TRANSPLANTATION DURING THE OUTBREAK OF CORONAVIRUS DISEASE 2019: EARLY EXPERIENCE FROM CHINA

SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We Stand?

Organ Transplantation Management in the Midst of the COVID-19 Outbreak: a Synopsis

Single-Center Experience Of Organ Transplant Practice During The Covid-19 Epidemic

Influence of Asymptomatic Carriers with COVID-19 on Transplantation Resumption in Wuhan

Clinical Characteristics of Novel Coronavirus Pneumonia in Organ Transplant Recipients and Management Strategy During the Epidemic(1st Edition)

Management strategies for lung transplant patients in COVID-19 epidemic areas

Ppa_a_337448 61..68

Immunology of Transplant Patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy.

Early impact of COVID‐19 on transplant center practices and policies in the United States

Clinical characteristics and epidemiology survey of lung transplantation recipients accepting surgeries during the COVID-19 pandemic:from area near Hubei Province

How Do We Manage Hematopoietic Cell Transplant During the SARS-CoV-2 Pandemic?

Prevention and Control Strategies for Emergency, Limited-Term, and Elective Operations in Pediatric Surgery During the Epidemic Period of COVID-19

Clinical Characteristics and Immunosuppressant Management of Coronavirus Disease 2019 in Solid Organ Transplant Recipients

Treatment of Pancreatic Diseases and Prevention of Infection During Outbreak of 2019 Coronavirus Disease

Management of COVID-19 in Patients after Liver Transplantation: Beijing Working Party for Liver Transplantation

Clinical characteristics and epidemiology survey of lung transplantation recipients accepting surgeries during COVID 19 pandemic:from area near Hubei Province (Preprint)

Bilateral lobar lung transplantation and a single lung transplantation using lungs from a single organ donor during coronavirus disease 2019 pandemic